30 September 2026
Hogan Lovells Cadwalader advises Ligand on financing agreement with AvenCell Therapeutics
Advising firms
Deal team
22 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Conor Larkin Lead | Hogan Lovells Cadwalader | Partner | M&A | Philadelphia/Houston |
| Bob Underwood Lead | Hogan Lovells Cadwalader | Partner | IP | Boston |
| Steve Nicolai Lead | Hogan Lovells Cadwalader | Partner | Securities & Public Company Advisory | Philadelphia |
| Gibby Baker | Hogan Lovells Cadwalader | Senior associate | M&A | Philadelphia |
| Garrett Welch | Hogan Lovells Cadwalader | Associate | General Corporate & Finance | Houston |
| Henry Watsky | Hogan Lovells Cadwalader | Counsel | Not stated | Northern Virginia |
| Michael Atkins | Hogan Lovells Cadwalader | Senior associate | IP | Washington, D.C. |
| Isabelle Dean | Hogan Lovells Cadwalader | Associate | IP | Washington, D.C. |
| Kayvon Stohler-Paul | Hogan Lovells Cadwalader | Associate | Securities and Public Company Advisory | Philadelphia |
| Matthew Schernecke | Hogan Lovells Cadwalader | Partner | Banking & Loan Finance | New York |
| Scott Friedman | Hogan Lovells Cadwalader | Partner | Tax, Pensions & Benefits | New York |
| Elizabeth Adams | Hogan Lovells Cadwalader | Senior associate | Tax, Pensions & Benefits | New York |
| Jacky Scanlan-Dyas | Hogan Lovells Cadwalader | Partner | Corporate & Finance | Tokyo |
| Owen Chan | Hogan Lovells Cadwalader | Partner | Not stated | Hong Kong |
| Thomas Freund | Hogan Lovells Cadwalader | Partner | Banking & Loan Finance | Munich |
| Heiko Tschauner | Hogan Lovells Cadwalader | Partner | RSS | Munich |
| Wataru Kamoto | Hogan Lovells Cadwalader | Not stated | M&A | Tokyo |
| Peter Gierl | Hogan Lovells Cadwalader | Counsel | Banking & Loan Finance | Munich |
| Derrick Lau | Hogan Lovells Cadwalader | Counsel | Banking & Loan Finance | Hong Kong |
| Julia Oelrich | Hogan Lovells Cadwalader | Other | Banking & Loan Finance | Munich |
| Madlen Riefler | Hogan Lovells Cadwalader | Associate | RSS | Munich |
| Will Tan | Hogan Lovells Cadwalader | Associate | M&A | Tokyo |
19 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 47m (US$47 million)
- What the figure measures
- Facility amount
- Client
- Ligand Pharmaceuticals IncorporatedBorrower
- Counterparties
- AvenCell Therapeutics, Inc. (Lenders)